Stock prices for Lucid Group rebound following a sharp six-day decline.
Lucid Group, the electric vehicle (EV) manufacturer, has experienced a significant drop in its share price over the past month, with a decrease of 23.92%. This downward trend continued over the previous six sessions, resulting in a total fall of 25.73%. However, on Friday, the company managed to rise 13.83% to close at $18.40.
Despite this recent rise, the year-to-date performance of Lucid Group (NASDAQ: LCID) has been disappointing, with a drop of 43.18%. The stock has also fallen to an all-time low on a split-adjusted basis, with the record low being $17.36 on September 02.
The consensus of around 12 analysts, as reported in the August 2025 summary comparing Rivian and Lucid, has given Lucid a Hold rating with a Quant-Rating of 2.53 out of 5. Seeking Alpha analysts also view the stock as a Hold. Jack Elias, another analyst, rates Lucid shares as a Hold at current levels.
Analyst Anna Sokolidou highlighted that Lucid Group has been recording negative profit margins for a while. Despite increasing sales, the company relies heavily on external funding. Jack Elias also identifies major risks for Lucid, including cash burn, weak profitability, and uncertain legislation.
In terms of growth, Lucid received a B from Seeking Alpha. However, the company received an F in the prospect of profitability and a D- in momentum from Seeking Alpha. It's worth noting that among Wall Street analysts, only one rates LCID as a Strong Buy, while 10 have given a Hold, and three recommended Sell or lower.
Despite the challenging outlook, Jack Elias believes that Lucid has promising growth potential through new EV models and partnerships. The company is set to enact a 1-for-10 reverse stock split, which could potentially stabilise the stock price in the short term.
In conclusion, while Lucid Group has faced significant challenges in recent months, there is a belief among some analysts that the company has the potential for growth through new products and partnerships. However, concerns remain about the company's profitability, cash burn, and reliance on external funding. Investors are advised to closely monitor the company's progress and seek advice from a financial advisor before making any investment decisions.
Read also:
- Understanding Hemorrhagic Gastroenteritis: Key Facts
- Stopping Osteoporosis Treatment: Timeline Considerations
- Trump's Policies: Tariffs, AI, Surveillance, and Possible Martial Law
- Expanded Community Health Involvement by CK Birla Hospitals, Jaipur, Maintained Through Consistent Outreach Programs Across Rajasthan
